Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Biohaven Ltd BHVN

Healthcare Biotechnology
Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its clinical and preclinical programs include Kv7 ion channel modulation for epilepsy and mood disorders; extracellular protein degradation for immunological diseases... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSE:BHVN)

Levi & Korsinsky Reminds Biohaven Ltd. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - BHVN

ACCESS Newswire 20 hours ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Biohaven Ltd. (BHVN) And Encourages Shareholders to Connect

ACCESS Newswire 20 hours ago

Investors who lost money on Biohaven Ltd. should contact Levi & Korsinsky about an ongoing investigation - BHVN

ACCESS Newswire 1 day ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd - BHVN

ACCESS Newswire 1 day ago

ATTENTION BHVN SHAREHOLDERS: Investors who lost money on Biohaven Ltd. are urged to contact Levi & Korsinsky about an ongoing investigation

ACCESS Newswire 2 days ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Biohaven Ltd. (BHVN) And Encourages Investors to Connect

ACCESS Newswire 2 days ago

BHVN STOCK ALERT: Levi & Korsinsky Notifies Biohaven Ltd. Investors of an Ongoing Investigation

ACCESS Newswire 3 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd - BHVN

ACCESS Newswire 3 days ago

Lost Money on Biohaven Ltd. (BHVN)? Contact Levi & Korsinsky Regarding an Ongoing Investigation

ACCESS Newswire 3 days ago
View More News ››

Opinion & Analysis (NYSE:BHVN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NYSE:BHVN)

Biohaven Announces Pricing of $250 Million Public Offering o

JUST IN: $BHVN Biohaven Announces Pricing of $250 Million Public Offering of Common SharesBiohaven Announces Pricing of $250 Million...
whytestocks - October 1, 2024
View more Bullboard ››

G Mining Ventures Corp.

G Mining Ventures Corp.

G Mining Ventures Corp. is a Canada-based mining company. The Company is engaged in the acquisition, exploration and ...
View More »